Exacerbation of chronic large plaque psoriasis associated with Olanzepine therapy [3]

Journal of the European Academy of Dermatology and Venereology

Volumn 14, Issue 4, 2000, Pages 315-316

  Ascari Raccagni, Antonio ^a   Baldari, Urbano ^a   Rossi, Emmanuela ^a   Alessandrini, Franco ^a  

^a MORGAGNI PIERANTONI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; CYCLOSPORIN; DOPAMINE RECEPTOR; MUSCARINIC RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; SEROTONIN RECEPTOR;

ADULT; BINDING AFFINITY; CASE REPORT; CLINICAL OBSERVATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOPAMINERGIC ACTIVITY; DRUG SELECTIVITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; PSYCHIATRIC DEPARTMENT; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MIDDLE AGED; PIRENZEPINE; PSORIASIS; SCHIZOPHRENIA;

EID: 0034427035     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2000.00056-3.x     Document Type: Letter

References (6)

1. Olanzapine induced mania
2. Olanzapine induced agranulocytosis (Letter)
3. Olanzapine induced neutropenia after clozapine induced neutropenia (Letter)
4. Marked elevation of serum creatine kinase associated with Olanzapine therapy
5. Severe akathisia during Olanzapine treatment of acute schizophrenia
6. Postular eruption induced by Olanzapine, a novel antipsychotic agent. J.